Tacrine (Cognex)

Although tacrine was marketed for many years as a respiratory stimulant, only recently has it been prescribed to treat the symptoms of mild to moderate Alzheimer's disease. Marketed under the trade name Cognex, the reversible cholinesterase inhibitor does not cure or slow the progression of the debilitating disease, but rather allows the patient to improve thinking ability.